USD 12.56
(2.95%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 35.1 Million CHF | 539.05% |
2022 | 5.49 Million CHF | 103.16% |
2021 | -173.85 Million CHF | -293.5% |
2020 | 89.84 Million CHF | -53.99% |
2019 | 195.28 Million CHF | 354.41% |
2018 | -76.76 Million CHF | 4.11% |
2017 | -80.05 Million CHF | -323.83% |
2016 | 35.76 Million CHF | 130.12% |
2015 | -118.72 Million CHF | 54.33% |
2014 | -259.98 Million CHF | -40.95% |
2013 | -184.45 Million CHF | -31.32% |
2012 | -140.45 Million CHF | 62.75% |
2011 | -377.05 Million CHF | -7.85% |
2010 | -349.6 Million CHF | -33.65% |
2009 | -261.57 Million CHF | -167.19% |
2008 | -97.9 Million CHF | -85.53% |
2007 | -52.76 Million CHF | 69.29% |
2006 | -171.8 Million CHF | -82.4% |
2005 | -94.19 Million CHF | 12.05% |
2004 | -107.1 Million CHF | -44.42% |
2003 | -74.16 Million CHF | -32.2% |
2002 | -56.09 Million CHF | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -84.51 Million CHF | 241.58% |
2023 FY | 35.1 Million CHF | 539.05% |
2023 Q4 | 35.1 Million CHF | -66.11% |
2023 Q2 | 103.56 Million CHF | 1785.4% |
2022 FY | 5.49 Million CHF | 103.16% |
2022 Q2 | -9.39 Million CHF | 94.6% |
2022 Q4 | 5.49 Million CHF | 158.46% |
2021 Q2 | 23.14 Million CHF | -74.24% |
2021 Q4 | -173.85 Million CHF | -851.25% |
2021 FY | -173.85 Million CHF | -293.5% |
2020 Q2 | 329.08 Million CHF | 68.51% |
2020 FY | 89.84 Million CHF | -53.99% |
2020 Q4 | 89.84 Million CHF | -72.7% |
2019 FY | 195.28 Million CHF | 354.41% |
2019 Q4 | 195.28 Million CHF | -40.03% |
2019 Q2 | 325.65 Million CHF | 524.24% |
2018 Q2 | 28.5 Million CHF | 135.61% |
2018 Q4 | -76.76 Million CHF | -369.27% |
2018 FY | -76.76 Million CHF | 4.11% |
2017 Q2 | 112.95 Million CHF | 215.82% |
2017 Q4 | -80.05 Million CHF | -170.87% |
2017 FY | -80.05 Million CHF | -323.83% |
2016 Q4 | 35.76 Million CHF | 135.24% |
2016 FY | 35.76 Million CHF | 130.12% |
2016 Q2 | -101.5 Million CHF | 14.51% |
2015 Q2 | 1.65 Million CHF | 100.64% |
2015 Q4 | -118.72 Million CHF | -7291.22% |
2015 FY | -118.72 Million CHF | 54.33% |
2014 Q4 | -259.98 Million CHF | -85.92% |
2014 FY | -259.98 Million CHF | -40.95% |
2014 Q2 | -139.83 Million CHF | 24.19% |
2013 Q2 | -117.21 Million CHF | 16.55% |
2013 FY | -184.45 Million CHF | -31.32% |
2013 Q4 | -184.45 Million CHF | -57.36% |
2012 Q2 | -116.89 Million CHF | 69.0% |
2012 FY | -140.45 Million CHF | 62.75% |
2012 Q4 | -140.45 Million CHF | -20.15% |
2011 Q4 | -377.05 Million CHF | -15.92% |
2011 Q2 | -325.27 Million CHF | 6.96% |
2011 FY | -377.05 Million CHF | -7.85% |
2010 FY | -349.6 Million CHF | -33.65% |
2010 Q4 | -349.6 Million CHF | -25.29% |
2010 Q2 | -279.02 Million CHF | -6.67% |
2009 Q4 | -261.57 Million CHF | 0.0% |
2009 FY | -261.57 Million CHF | -167.19% |
2008 FY | -97.9 Million CHF | -85.53% |
2007 FY | -52.76 Million CHF | 69.29% |
2006 FY | -171.8 Million CHF | -82.4% |
2005 FY | -94.19 Million CHF | 12.05% |
2004 FY | -107.1 Million CHF | -44.42% |
2003 FY | -74.16 Million CHF | -32.2% |
2002 FY | -56.09 Million CHF | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
American Medical Technologies Inc. | 479.63 Thousand USD | -7218.751% |
Ansell Limited | -54.99 Million USD | 163.827% |
Ansell Limited | -55.1 Million USD | 163.708% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | -36.49 Million USD | 196.191% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | -105.1 Thousand USD | 33498.984% |
Psykey, Inc. | 634.59 Thousand USD | -5431.577% |
ConvaTec Group Plc | 1.2 Billion USD | 97.076% |
ConvaTec Group Plc | 1.2 Billion USD | 97.08% |
Encision Inc. | 1.29 Million USD | -2619.702% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | 2.3 Million USD | -1420.455% |
Innovative MedTech Inc. | 1.76 Million USD | -1889.136% |
LifePoint, Inc. | -3.26 Million USD | 1175.453% |
Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -615.777% |
Paradigm Medical Industries, Inc. | 2.16 Million USD | -1523.636% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | -43.3 Thousand USD | 81161.796% |
Reflect Scientific, Inc. | -1.03 Million USD | 3490.588% |
SmileDirectClub, Inc. | 778.67 Million USD | 95.492% |
Sector 10, Inc. | 163 Thousand USD | -21435.583% |
Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 108.407% |
SheerVision, Inc. | 57.34 Thousand USD | -61109.437% |
United Health Products, Inc. | 660.56 Thousand USD | -5214.055% |
Vasamed, Inc. | 22.12 Thousand USD | -158579.143% |
Wearable Health Solutions, Inc. | 2.63 Million USD | -1234.096% |
Yubo International Biotech Limited | 772.27 Thousand USD | -4445.378% |